Hilal Arnouk, Ph.D. - Publications

Affiliations: 
2005 State University of New York, Buffalo, Buffalo, NY, United States 
Area:
Immunology, Pathology, Oncology

10 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2013 Knight A, Arnouk H, Britt W, Gillespie GY, Cloud GA, Harkins L, Su Y, Lowdell MW, Lamb LS. CMV-independent lysis of glioblastoma by ex vivo expanded/activated Vδ1+ γδ T cells. Plos One. 8: e68729. PMID 23950874 DOI: 10.1371/Journal.Pone.0068729  0.338
2011 Bryant NL, Gillespie GY, Lopez RD, Markert JM, Cloud GA, Langford CP, Arnouk H, Su Y, Haines HL, Suarez-Cuervo C, Lamb LS. Preclinical evaluation of ex vivo expanded/activated γδ T cells for immunotherapy of glioblastoma multiforme. Journal of Neuro-Oncology. 101: 179-88. PMID 20532954 DOI: 10.1007/S11060-010-0245-2  0.374
2010 Arnouk H, Zynda ER, Wang XY, Hylander BL, Manjili MH, Repasky EA, Subjeck JR, Latif Kazim A. Tumour secreted grp170 chaperones full-length protein substrates and induces an adaptive anti-tumour immune response in vivo. International Journal of Hyperthermia : the Official Journal of European Society For Hyperthermic Oncology, North American Hyperthermia Group. 26: 366-75. PMID 20210603 DOI: 10.3109/02656730903485910  0.344
2007 Sharma S, Tammela J, Wang X, Arnouk H, Driscoll D, Mhawech-Fauceglia P, Lele S, Kazim AL, Odunsi K. Characterization of a putative ovarian oncogene, elongation factor 1alpha, isolated by panning a synthetic phage display single-chain variable fragment library with cultured human ovarian cancer cells. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 13: 5889-96. PMID 17908984 DOI: 10.1158/1078-0432.Ccr-07-0703  0.527
2006 Manjili MH, Arnouk H, Knutson KL, Kmieciak M, Disis ML, Subjeck JR, Kazim AL. Erratum to: Emergence of immune escape variant of mammary tumors that has distinct proteomic profile and a reduced ability to induce "danger signals". Breast Cancer Research and Treatment. 96: 243. PMID 28303485 DOI: 10.1007/S10549-006-9163-6  0.581
2006 Wang XY, Arnouk H, Chen X, Kazim L, Repasky EA, Subjeck JR. Extracellular targeting of endoplasmic reticulum chaperone glucose-regulated protein 170 enhances tumor immunity to a poorly immunogenic melanoma. Journal of Immunology (Baltimore, Md. : 1950). 177: 1543-51. PMID 16849461 DOI: 10.4049/Jimmunol.177.3.1543  0.482
2006 Kulawiec M, Arnouk H, Desouki MM, Kazim L, Still I, Singh KK. Proteomic analysis of mitochondria-to-nucleus retrograde response in human cancer. Cancer Biology & Therapy. 5: 967-75. PMID 16775426 DOI: 10.4161/Cbt.5.8.2880  0.379
2006 Manjili MH, Arnouk H, Knutson KL, Kmieciak M, Disis ML, Subjeck JR, Kazim AL. Emergence of immune escape variant of mammary tumors that has distinct proteomic profile and a reduced ability to induce "danger signals". Breast Cancer Research and Treatment. 96: 233-41. PMID 16211331 DOI: 10.1007/S10549-005-9044-4  0.598
2006 Facciponte JG, Wang XY, MacDonald IJ, Park JE, Arnouk H, Grimm MJ, Li Y, Kim H, Manjili MH, Easton DP, Subjeck JR. Heat shock proteins HSP70 and GP96: structural insights. Cancer Immunology, Immunotherapy : Cii. 55: 339-46. PMID 16032399 DOI: 10.1007/S00262-005-0020-Y  0.435
2006 Kulawiec M, Arnouk H, Desouki M, Kazim L, Still I, Singh K. Proteomic analysis of mitochondria-to-nucleus retrograde response in human cancer cells Mitochondrion. 6: 16-17. DOI: 10.1016/J.Mito.2006.08.039  0.342
Show low-probability matches.